Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei Dang

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Plos One|July 25, 2014
Lactoferrin deficiency promotes colitis-associated colorectal dysplasia in miceQiurong Ye, Ying Zheng, Songqing Fan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 29, 2026
Phase Ib/II Study of Preliminary Efficacy, Safety and Pharmacodynamics of MG-K10, a Humanised Monoclonal Antibody Targeting IL-4Rα, in Adult Chinese Patients With AsthmaMo Xian, Xu Shi, Ruoran Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Engineered antibody Fc variants with enhanced effector functionGreg A Lazar, Wei Dang, Sher Karki, et al.
Journal of Translational Medicine|May 19, 2016
PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinomaXiao-Bin Cui, Shu-Mao Zhang, Yue-Xun Xu, et al.
Frontiers in Psychiatry|July 25, 2022
Heterogenous Subtypes of Late-Life Depression and Their Cognitive Patterns: A Latent Class AnalysisLi-Qi Wang, Tian-Hong Zhang, Wei Dang, et al.
Science Translational Medicine|April 6, 2018
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Cell|January 20, 2023
Opioid-induced fragile-like regulatory T cells contribute to withdrawalYongsheng Zhu, Peng Yan, Rui Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 11, 2020
Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCsLizhao Feng, Jianfei Chao, E Tian, et al.
Chinese Journal of Integrative Medicine|April 3, 2024
Naoxueshu Oral Liquid Accelerates Post-Craniotomy Hematoma Absorption in Patients: An Open-Label, Multicenter, and Randomized Controlled TrialQiu He, Fu-Xin Lin, Jin-Ye Su, et al.
Translational Vision Science & Technology|October 6, 2021
One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular DegenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Plos One|July 25, 2014
Lactoferrin deficiency promotes colitis-associated colorectal dysplasia in miceQiurong Ye, Ying Zheng, Songqing Fan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 29, 2026
Phase Ib/II Study of Preliminary Efficacy, Safety and Pharmacodynamics of MG-K10, a Humanised Monoclonal Antibody Targeting IL-4Rα, in Adult Chinese Patients With AsthmaMo Xian, Xu Shi, Ruoran Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Engineered antibody Fc variants with enhanced effector functionGreg A Lazar, Wei Dang, Sher Karki, et al.
Journal of Translational Medicine|May 19, 2016
PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinomaXiao-Bin Cui, Shu-Mao Zhang, Yue-Xun Xu, et al.
Frontiers in Psychiatry|July 25, 2022
Heterogenous Subtypes of Late-Life Depression and Their Cognitive Patterns: A Latent Class AnalysisLi-Qi Wang, Tian-Hong Zhang, Wei Dang, et al.
Science Translational Medicine|April 6, 2018
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Cell|January 20, 2023
Opioid-induced fragile-like regulatory T cells contribute to withdrawalYongsheng Zhu, Peng Yan, Rui Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 11, 2020
Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCsLizhao Feng, Jianfei Chao, E Tian, et al.
Chinese Journal of Integrative Medicine|April 3, 2024
Naoxueshu Oral Liquid Accelerates Post-Craniotomy Hematoma Absorption in Patients: An Open-Label, Multicenter, and Randomized Controlled TrialQiu He, Fu-Xin Lin, Jin-Ye Su, et al.
Translational Vision Science & Technology|October 6, 2021
One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular DegenerationAmir H Kashani, Jane S Lebkowski, Firas M Rahhal, et al.
Pageof 19